RxDoctor Payments Data

Elyse Harris, MD

Hematology-Oncology · Madison, WINPI 1215324090

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

Too few hematology-oncology providers in Wisconsinto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$2,186,658
Medicare patients
430
Services billed
100,114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JakafiRuxolitinib Phosphate11$190,477
BrukinsaZanubrutinib12$176,126
VenclextaVenetoclax18$171,322
Abiraterone Acetate33$57,289
EliquisApixaban42$40,852
OrgovyxRelugolix12$32,823
Imatinib Mesylate26$11,598
Hydroxyurea97$2,919
Tamoxifen Citrate68$2,032
Anastrozole142$1,782
Acyclovir112$958
Mirtazapine26$703
Pantoprazole Sodium30$658
Mycophenolate Mofetil21$630
Dexamethasone34$592

Paid to pharmacies, not to this prescriber.

Other hematology-oncology in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →